21 CFR 522.230
§ 522.230 Buprenorphine.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 522.230, § 522.230 Buprenorphine, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87397
- Permanent ID
ys:prov:87397@1- SHA-256
e0ff42ed17ce4dcd58d12278f79ddc659f5119580eb09ffc8b6ef8a900e5bc26
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of solution contains 1.8 milligrams (mg) buprenorphine.
(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Conditions of use in cats—(1) Amount. Administer 0.24 mg per kilogram (0.11 mg per pound) by subcutaneous injection once daily, for up to 3 days. Administer the first dose approximately 1 hour prior to surgery.
(2) Indications for use. For the control of postoperative pain associated with surgical procedures in cats.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.